Forsta AP Fonden Trims Holdings in Nutrien Ltd. (NYSE:NTR)

Forsta AP Fonden lessened its stake in Nutrien Ltd. (NYSE:NTRFree Report) by 1.7% in the fourth quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission. The fund owned 123,300 shares of the company’s stock after selling 2,100 shares during the period. Forsta AP Fonden’s holdings in Nutrien were worth $5,514,000 at the end of the most recent reporting period.

Several other institutional investors have also recently added to or reduced their stakes in NTR. Central Pacific Bank Trust Division bought a new stake in shares of Nutrien in the 3rd quarter worth about $28,000. Exchange Traded Concepts LLC raised its stake in Nutrien by 96.7% during the fourth quarter. Exchange Traded Concepts LLC now owns 846 shares of the company’s stock valued at $38,000 after buying an additional 416 shares in the last quarter. Point72 Asia Singapore Pte. Ltd. bought a new position in Nutrien during the 2nd quarter worth approximately $52,000. Union Bancaire Privee UBP SA acquired a new position in shares of Nutrien in the 4th quarter worth approximately $67,000. Finally, Larson Financial Group LLC increased its holdings in shares of Nutrien by 1,370.6% in the 3rd quarter. Larson Financial Group LLC now owns 1,603 shares of the company’s stock valued at $77,000 after acquiring an additional 1,494 shares during the last quarter. 63.10% of the stock is owned by institutional investors and hedge funds.

Nutrien Price Performance

NYSE NTR opened at $51.65 on Friday. The firm has a market capitalization of $25.36 billion, a PE ratio of 34.66, a P/E/G ratio of 1.19 and a beta of 0.81. The company has a debt-to-equity ratio of 0.38, a current ratio of 1.27 and a quick ratio of 0.82. Nutrien Ltd. has a 12 month low of $43.69 and a 12 month high of $60.87. The company’s 50 day simple moving average is $48.14 and its 200 day simple moving average is $48.09.

Nutrien (NYSE:NTRGet Free Report) last posted its quarterly earnings data on Wednesday, November 6th. The company reported $0.39 EPS for the quarter, missing analysts’ consensus estimates of $0.43 by ($0.04). Nutrien had a return on equity of 6.99% and a net margin of 2.79%. The firm had revenue of $5.35 billion during the quarter, compared to the consensus estimate of $5.26 billion. During the same period in the prior year, the firm posted $0.35 EPS. The firm’s quarterly revenue was down 5.0% on a year-over-year basis. As a group, equities research analysts forecast that Nutrien Ltd. will post 3.49 EPS for the current fiscal year.

Nutrien Increases Dividend

The firm also recently disclosed a quarterly dividend, which was paid on Friday, January 17th. Stockholders of record on Tuesday, December 31st were given a dividend of $0.939 per share. This is a positive change from Nutrien’s previous quarterly dividend of $0.54. The ex-dividend date of this dividend was Tuesday, December 31st. This represents a $3.76 annualized dividend and a dividend yield of 7.27%. Nutrien’s dividend payout ratio (DPR) is 144.97%.

Analyst Upgrades and Downgrades

A number of equities analysts have commented on the stock. Wells Fargo & Company lifted their price objective on shares of Nutrien from $52.00 to $53.00 and gave the stock an “equal weight” rating in a report on Tuesday. UBS Group boosted their price objective on shares of Nutrien from $51.00 to $53.00 and gave the company a “neutral” rating in a research report on Tuesday. Barclays reissued an “equal weight” rating and issued a $56.00 target price (up previously from $55.00) on shares of Nutrien in a report on Tuesday, January 21st. Piper Sandler upped their target price on Nutrien from $58.00 to $63.00 and gave the company an “overweight” rating in a report on Monday, January 27th. Finally, Oppenheimer assumed coverage on Nutrien in a report on Thursday, December 12th. They issued an “outperform” rating and a $60.00 price target on the stock. One investment analyst has rated the stock with a sell rating, six have issued a hold rating and ten have assigned a buy rating to the company. According to data from MarketBeat.com, the company has a consensus rating of “Moderate Buy” and a consensus price target of $58.94.

Get Our Latest Stock Analysis on NTR

Nutrien Company Profile

(Free Report)

Nutrien Ltd. provides crop inputs and services. The company operates through four segments: Retail, Potash, Nitrogen, and Phosphate. The Retail segment distributes crop nutrients, crop protection products, seeds, and merchandise products. The Potash segment provides granular and standard potash products.

Recommended Stories

Want to see what other hedge funds are holding NTR? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Nutrien Ltd. (NYSE:NTRFree Report).

Institutional Ownership by Quarter for Nutrien (NYSE:NTR)

Receive News & Ratings for Nutrien Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Nutrien and related companies with MarketBeat.com's FREE daily email newsletter.